Inovio Pharmaceuticals
INO
#8735
Rank
โ‚น22.80 B
Marketcap
โ‚น126.94
Share price
-6.55%
Change (1 day)
-33.44%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2026 (TTM): -โ‚น7.53 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น8.42 Billion, an increase over its 2024 earnings that were of -โ‚น10.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น7.53 Billion-10.63%
2025 -โ‚น8.42 Billion-16.07%
2024 -โ‚น10.04 Billion-20.03%
2023 -โ‚น12.55 Billion-51.56%
2022 -โ‚น25.9 Billion-8.26%
2021 -โ‚น28.23 Billion95.4%
2020 -โ‚น14.45 Billion36.62%
2019 -โ‚น10.58 Billion20.19%
2018 -โ‚น8.8 Billion10.94%
2017 -โ‚น7.93 Billion9.59%
2016 -โ‚น7.24 Billion118.9%
2015 -โ‚น3.31 Billion-10.67%
2014 -โ‚น3.7 Billion83.32%
2013 -โ‚น2.02 Billion
2011 -โ‚น2.09 Billion15.64%
2010 -โ‚น1.81 Billion37.7%
2009 -โ‚น1.31 Billion2.19%
2008 -โ‚น1.28 Billion-14.09%
2007 -โ‚น1.49 Billion19.12%
2006 -โ‚น1.26 Billion9.62%
2005 -โ‚น1.15 Billion5.77%
2004 -โ‚น1.08 Billion73.08%
2003 -โ‚น0.63 Billion12.75%
2002 -โ‚น0.56 Billion
2000 -โ‚น0.84 Billion53.93%
1999 -โ‚น0.55 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.753 T-22,845.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.184 T-15,460.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น652.76 B-8,565.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-โ‚น237.3 Billion 2,977.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น629.81 B-8,268.27%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น670.23 B-8,792.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
-โ‚น0.26 Billion-96.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น14.94 Billion 93.75%๐Ÿ‡บ๐Ÿ‡ธ USA